Metabolic reprogramming of astrocytes: Emerging roles of lactate

Lactate serves as a key energy metabolite in the central nervous system, facilitating essential brain functions, including energy supply, signaling, and epigenetic modulation. Moreover, it links epigenetic modifications with metabolic reprogramming. Nonetheless, the specific mechanisms and roles of this connection in astrocytes remain unclear. Therefore, this review aims to explore the role and specific mechanisms of lactate in the metabolic reprogramming of astrocytes in the central nervous system. The close relationship between epigenetic modifications and metabolic reprogramming was discussed. Therapeutic strategies for targeting metabolic reprogramming in astrocytes in the central nervous system were also outlined to guide future research in central nervous system diseases. In the nervous system, lactate plays an essential role. However, its mechanism of action as a bridge between metabolic reprogramming and epigenetic modifications in the nervous system requires future investigation. The involvement of lactate in epigenetic modifications is currently a hot research topic, especially in lactylation modification, a key determinant in this process. Lactate also indirectly regulates various epigenetic modifications, such as N6-methyladenosine, acetylation, ubiquitination, and phosphorylation modifications, which are closely linked to several neurological disorders. In addition, exploring the clinical applications and potential therapeutic strategies of lactic acid provides new insights for future neurological disease treatments.

External stimuli-responsive drug delivery to the posterior segment of the eye

Posterior segment eye diseases represent the leading causes of vision impairment and blindness globally. Current therapies still have notable drawbacks, including the need for frequent invasive injections and the associated risks of severe ocular complications. Recently, the utility of external stimuli, such as light, ultrasound, magnetic field, and electric field, has been noted as a promising strategy to enhance drug delivery to the posterior segment of the eye. In this review, we briefly summarize the main physiological barriers against ocular drug delivery, focusing primarily on the recent advancements that utilize external stimuli to improve treatment outcomes for posterior segment eye diseases. The advantages of these external stimuli-responsive drug delivery strategies are discussed, with illustrative examples highlighting improved tissue penetration, enhanced control over drug release, and targeted drug delivery to ocular lesions through minimally invasive routes. Finally, we discuss the challenges and future perspectives in the translational research of external stimuli-responsive drug delivery platforms, aiming to bridge existing gaps toward clinical use.

Electrochemical biosensing in oncology: a review advancements and prospects for cancer diagnosis

Early and precise diagnosis of cancer is pivotal for effective therapeutic intervention. Traditional diagnostic methods, despite their reliability, often face limitations such as invasiveness, high costs, labor-intensive procedures, extended processing times, and reduced sensitivity for early-stage detection. Electrochemical biosensing is a revolutionary method that provides rapid, cost-effective, and highly sensitive detection of cancer biomarkers. This review discusses the use of electrochemical detection in biosensors to provide real-time insights into disease-specific molecular interactions, focusing on target recognition and signal generation mechanisms. Furthermore, the superior efficacy of electrochemical biosensors compared to conventional techniques is explored, particularly in their ability to detect cancer biomarkers with enhanced specificity and sensitivity. Advancements in electrode materials and nanostructured designs, integrating nanotechnology, microfluidics, and artificial intelligence, have the potential to overcome biological interferences and scale for clinical use. Research and innovation in oncology diagnostics hold potential for personalized medicine, despite challenges in commercial viability and real-world application.

Quantifying antibody binding: techniques and therapeutic implications

The binding kinetics of an antibody for its target antigen represent key determinants of its biological function and success as a novel biotherapeutic. Defining these interactions and kinetics is critical for understanding the pharmacological and pharmacodynamic profiles of antibodies in therapeutic applications, with line of sight to clinical translation. In this review, we discuss the latest developments in approaches to measure and modulate antibody-antigen interactions, including antibody engineering, novel antibody formats, current, and emerging technologies for measuring antibody-antigen binding interactions, and emerging perspectives within the field. We also explore how emerging computational methods are set to become powerful tools for modeling antibody-binding interactions under physiologically relevant conditions. Finally, we consider the therapeutic implications of modulating target engagement in terms of pharmacodynamics and pharmacokinetics.

The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy

Cisplatin is a platinum-based drug that is frequently used to treat multiple tumors. The anti-tumor effect of cisplatin is closely related to the tumor immune microenvironment (TIME), which includes several immune cell types, such as the tumor-associated macrophages (TAMs), cytotoxic T-lymphocytes (CTLs), dendritic cells (DCs), myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), and natural killer (NK) cells. The interaction between these immune cells can promote tumor survival and chemoresistance, and decrease the efficacy of cisplatin monotherapy. Therefore, various combination treatment strategies have been devised to enhance patient responsiveness to cisplatin therapy. Cisplatin can augment anti-tumor immune responses in combination with immune checkpoint blockers (such as PD-1/PD-L1 or CTLA4 inhibitors), lipid metabolism disruptors (like FASN inhibitors and SCD inhibitors) and nanoparticles (NPs), resulting in better outcomes. Exploring the interaction between cisplatin and the TIME will help identify potential therapeutic targets for improving the treatment outcomes in cancer patients.

Multifaceted role of nitric oxide in vascular dementia

Vascular dementia is a highly heterogeneous neurodegenerative disorder induced by a variety of factors. Currently, there are no definitive treatments for the cognitive dysfunction associated with vascular dementia. However, early detection and preventive measures have proven effective in reducing the risk of onset and improving patient prognosis. Nitric oxide plays an integral role in various physiological and pathological processes within the central nervous system. In recent years, nitric oxide has been implicated in the regulation of synaptic plasticity and has emerged as a crucial factor in the pathophysiology of vascular dementia. At different stages of vascular dementia, nitric oxide levels and bioavailability undergo dynamic alterations, with a marked reduction in the later stages, which significantly contributes to the cognitive deficits associated with the disease. This review provides a comprehensive review of the emerging role of nitric oxide in the physiological and pathological processes underlying vascular dementia, focusing on its effects on synaptic dysfunction, neuroinflammation, oxidative stress, and blood‒brain barrier integrity. Furthermore, we suggest that targeting the nitric oxide soluble guanylate cyclase-cyclic guanosine monophosphate pathway through specific therapeutic strategies may offer a novel approach for treating vascular dementia, potentially improving both cognitive function and patient prognosis. The review contributes to a better understanding of the multifaceted role of nitric oxide in vascular dementia and to offering insights into future therapeutic interventions.

Leveraging deep learning for epigenetic protein prediction: a novel approach for early lung cancer diagnosis and drug discovery

Epigenetic protein (EP) plays a crucial role in influencing disease development, controlling gene expression, and shaping cell identity. They hold potential as targets for future therapies, and studying their mechanisms can lead to improved diagnosis and treatment strategies for various diseases. Anticipating EP is imperative, yet conventional experimental approaches for prediction prove time-intensive and expensive. This work constructed CNN-BiLSTM, computational method for identification of EP prediction. Utilizing primary sequences, two datasets were constructed, and an amphiphilic pseudo amino acid, group dipeptide composition and group amino acid composition were devised to extract numerical features. Model training incorporated a suite of deep learning architectures, including BiLSTM, GRU, and CNN. Notably, an ensemble model combining CNN and BiLSTM, trained using AmpPseAAC features, demonstrated superior performance across both training and testing datasets compared to other predictors. This research contributes to the ongoing efforts to revolutionize therapeutic approaches by facilitating the identification of novel drug targets and improving disease treatment outcomes.

Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management

Silicosis represents a formidable occupational lung pathology precipitated by the pulmonary assimilation of respirable crystalline silica particulates. This condition engenders a cascade of cellular oxidative stress via the activation of bioavailable silica, culminating in the generation of reactive oxygen species (ROS). Such oxidative mechanisms lead to irrevocable pulmonary impairment. Contemporary scholarly examinations have underscored the substantial antioxidative efficacy of platinum nanoparticles (PtNPs), postulating their utility as an adjunct therapeutic modality in silicosis management. The physicochemical interaction between PtNPs and silica demonstrates a propensity for adsorption, thereby facilitating the amelioration and subsequent pulmonary clearance of silica aggregates. In addition to their detoxifying attributes, PtNPs exhibit pronounced anti-inflammatory and antioxidative activities, which can neutralize ROS and inhibit macrophage-mediated inflammatory processes. Such attributes are instrumental in attenuating inflammatory responses and forestalling subsequent lung tissue damage. This discourse delineates the interplay between ROS and PtNPs, the pathogenesis of silicosis and its progression to pulmonary fibrosis, and critically evaluates the potential adjunct role of PtNPs in the therapeutic landscape of silicosis, alongside a contemplation of the inherent limitations associated with PtNPs application in this context.

Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines

Cervical cancer, the fourth most common cancer globally and the second most prevalent cancer among women in India, is primarily caused by Human Papilloma Virus (HPV). The association of diet with cancer etiology and prevention has been well established and nutrition has been shown to regulate cancer through modulation of epigenetic markers. Dietary fatty acids, especially omega-3, reduce the risk of cancer by preventing or reversing the progression through a variety of cellular targets, including epigenetic regulation. In this work, we have evaluated the potential of ALA (α linolenic acid), an ω-3 fatty acid, to regulate cervical cancer through epigenetic mechanisms. The effect of ALA was evaluated on the regulation of histone deacetylases1, DNA methyltransferases 1, and 3b, and global DNA methylation by ELISA. RT-PCR was utilized to assess the expression of tumor regulatory genes (hTERT, DAPK, RARβ, and CDH1) and their promoter methylation in HeLa (HPV18-positive), SiHa (HPV16-positive) and C33a (HPV-negative) cervical cancer cell lines. ALA increased DNA demethylase, HMTs, and HATs while decreasing global DNA methylation, DNMT, HDMs, and HDACs mRNA expression/activity in all cervical cancer cell lines. ALA downregulated hTERT oncogene while upregulating the mRNA expression of TSGs (Tumor Suppressor Genes) CDH1, RARβ, and DAPK in all the cell lines. ALA reduced methylation in the 5' CpG island of CDH1, RARβ, and DAPK1 promoters and reduced global DNA methylation in cervical cancer cell lines. These results suggest that ALA regulates the growth of cervical cancer cells by targeting epigenetic markers, shedding light on its potential therapeutic role in cervical cancer management.

Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations

The development of site-specific dual-payload antibody-drug conjugates (ADCs) represents a potential advancement in targeted cancer therapy, enabling the simultaneous delivery of two distinct drugs into the same cancer cells to overcome payload resistance and enhance therapeutic efficacy. Here, we examine various methodologies for achieving site-specific dual-payload conjugation, including the use of multi-functional linkers, canonical amino acids, non-canonical amino acids, and enzyme-mediated methods, all of which facilitate precise control over payload attachment while ensuring homogeneity. We explore the implications of different conjugation techniques on drug-to-antibody ratios and the ratios of the two payloads, as well as their impact on process complexity and manufacturability. Additionally, we address the potential advantages of dual-payload ADCs compared to ADCs combined with traditional chemotherapy or single-payload ADC/ADC combinations. By evaluating these innovative methods, we aim to provide a comprehensive understanding of the current landscape in dual-payload ADC development and outline emerging directions necessary for further advancement of this promising therapeutic strategy.

Smooth muscle extracellular matrix modified small intestinal submucosa conduits promote peripheral nerve repair

Challenges still exist to develop an ideal cell-free nerve guidance conduit (NGC) providing a favorable microenvironment for rapid and successful nerve regeneration. Proteomic analysis revealed that extracellular matrix (ECM) derived from smooth muscle cells (SMCs) was abundant in nerve-related active proteins and significantly enriched signaling pathways involved in nerve regeneration. However, whether NGCs based on SMCs-derived ECM modification strategy promote nerve regeneration remains unclear. In the study, we investigated the neuroregenerative effect of SMCs-derived ECM and developed a novel NGC (MyoNerve) by coating small intestinal submucosa (SIS) with SMCs-derived ECM. The SMCs-ECM was rich in neurotrophic factors, which endowed MyoNerve with remarkable neuroregenerative capabilities by promoting the expression of genes implicated in aspects of neuronal maintenance and activating signaling pathways involved in nerve regeneration. In vitro, MyoNerve exhibited excellent bioactivity for accelerating angiogenesis, regulating macrophages polarization, promoting the proliferation, migration and elongation of Schwann cells, enhancing differentiation of PC12 cells, and inducing the neurite outgrowth of dorsal root ganglia. In the model of rat sciatic nerve 10 mm defect, MyoNerve showed great potential for functional nerve regeneration by promoting angiogenesis, proliferation and migration of Schwann cells and neuron, axonal regeneration, remyelination, and neurological functional recovery.

MRI-responsive nanoprobes for visualizing hydrogen peroxide in diabetic liver injury

Diabetic liver injury has emerged as a significant complication associated with diabetes, warranting increased attention. The generation of hydrogen peroxide (H2O2) due to oxidative stress plays a critical role in the onset and progression of this condition. Despite this, there is a scarcity of probes capable of non-invasively, accurately, and reliably visualizing H2O2 levels in deep-seated liver in diabetes-induced liver injury. In this study, we introduce a novel H2O2-responsive magnetic probe (H2O2-RMP), designed for the sensitive imaging of H2O2 in the liver injury caused by diabetes. H2O2-RMP is synthesized through the co-precipitation of a H2O2-responsive amphiphilic polymer, manganese(III) porphyrin (Mn-porphyrin), and iron oxide nanoparticles. When exposed to H2O2, the released iron oxide nanoparticles aggregate, resulting in an increased T2-weighted MR signal intensity. H2O2-RMP not only demonstrates a wide dynamic response range (initial r2 = 9.87 mM-1s-1, Δr2 = 7.69 mM-1s-1), but also exhibits superior selectivity for H2O2 compared to other reactive oxygen species. Importantly, H2O2-RMP exhibits high sensitivity, with a detection limit for hydrogen peroxide as low as 0.56 μM. Moreover, H2O2-RMP has been effectively applied for real-time imaging of H2O2 levels in the livers of diabetic model mice with varying degrees of severity, highlighting its potential for visual diagnosis and monitoring the progression of diabetic liver injury.

A remotely controlled nanotherapeutic with immunomodulatory property for MRSA-induced bone infection

Osteomyelitis is a deep bone tissue infection caused by pathogenic microorganisms, with the primary pathogen being methicillin-resistant Staphylococcus aureus (MRSA). Due to the tendency of the infection site to form biofilms that shield drugs and immune cells to kill bacteria, combined with the severe local inflammatory response causing bone tissue destruction, the treatment of osteomyelitis poses a significant challenge. Herein, we developed a remotely controlled nanotherapeutic (TLBA) with immunomodulatory to treat MRSA-induced osteomyelitis. TLBA, combined with baicalin and gold nanorods, is positively charged to actively target and penetrate biofilms. Near-infrared light (808 nm) triggers spatiotemporal, controllable drug release, while bacteria are eliminated through synergistic interaction of non-antibiotic drugs and photothermal therapy, enhancing bactericidal efficiency and minimizing drug resistance. TLBA eliminated nearly 100 % of planktonic bacteria and dispersed 90 % of biofilms under NIR light stimulation. In MRSA-induced osteomyelitis rat models, laser irradiation raised the infection site temperature to 50 °C, effectively eradicating bacteria, promoting M2 macrophage transformation, inhibiting bone inflammation, curbing bone destruction, and fostering bone tissue repair. In summary, TLBA proposes a more comprehensive treatment strategy for the two characteristic pathological changes of bacterial infection and bone tissue damage in osteomyelitis.

Living therapeutics: Precision diagnosis and therapy with engineered bacteria

Bacteria-based therapy has emerged as a promising strategy for cancer treatment, offering the potential for targeted tumor delivery, immune activation, and modulation of the tumor microenvironment. However, the unpredictable behavior, safety concerns, and limited efficacy of wild-type bacteria pose significant challenges to their clinical translation. Recent advancements in synthetic biology and chemical engineering have enabled the development of precisely engineered bacterial platforms with enhanced controllability, targeted delivery, and reduced toxicity. This review summarize the current progress of engineered bacteria in cancer therapy. We first introduce the theoretical underpinnings and key advantages of bacterial therapies in cancer. Subsequently, we delve into the applications of genetic engineering and chemical modification techniques to enhance their therapeutic potential. Finally, we address critical challenges and future prospects, with a focus on improving safety and efficacy. This review aims to stimulate further research and provide valuable insights into the development of engineered bacterial therapies for precision oncology.

Engineered gold nanoparticles for accurate and full-scale tumor treatment via pH-dependent sequential charge-reversal and copper triggered photothermal-chemodynamic-immunotherapy

Current anti-tumor strategies majorly rely on the targeted delivery of functional nanomedicines to tumor region, neglecting the importance of effective infiltration of these nanomedicines in whole tumor tissue. This process normally causes the quick endocytosis by the tumor cells at surface layer of tumor tissue, resulting in the restriction of the penetration of these nanomedicines and limited therapeutic region, which would not be able to treat the entire tumor tissue. Herein, we prepared a series of engineered gold nanoparticles (Au-MBP NPs) with step-wise charge reversal in different acid environments that could entirely infiltrate into the whole tumor tissue and then perform tumor-specific photothermal-chemodynamic-immunotherapy to achieve the complete and accurate tumor treatment. These Au-MBP NPs consisted of AuNPs, thiol modified piperidine (SH-PD, charge reversal group), thiol modified benzoyl thiourea (SH-BTU, copper chelator) and 11-mercaptoundecanoic acid (MUA) with different proportions. Once these Au-MBP NPs arrived tumor tissue, the decreasing pH values from shallow to deep region of tumor tissue separately induced the charge reversal of these nanoparticles from negative to positive, allowing them to bind with negatively charged tumor cells at designed area to occupy the whole tumor for further therapy. Following with the internalization by tumor cells, these Au-MBP NPs would selectively capture the excessive Cu2+ to decrease the available copper in tumor cells, resulting in the inhibition of tumor metastasis via the copper metabolism blockade. On one hand, the captured Cu2+ also induced the aggregation of Au-MBP NPs, which in situ generated the photothermal agents in tumor cells for tumor-specific photothermal therapy (PTT). On the other hand, the chelated Cu2+ ions were reduced to Cu+, which catalyzed the high concentration of intracellular H2O2 to produce cytotoxic hydroxyl radical (•OH), exerting tumor-specific chemodynamic therapy (CDT). Furthermore, the immune-associated tumor antigens were also generated during PTT and CDT processes via immunogenic cell death (ICD), which further matured the dendritic cells (DCs) and then activated CD4+ and CD8+ T cells to turn on the immunotherapy, resulting in additional anti-tumor and anti-metastasis effects. Both in vitro and in vivo results indicated that these Au-MBP NPs possessed enormous potential for effectively suppressing primary and metastatic tumors.

Glucose-triggered NO-evolving coating bestows orthopedic implants with enhanced anti-bacteria and angiectasis for safeguarding diabetic osseointegration

As a common chronic metabolic disease, diabetes mellitus (DM) features a hyperglycemic micromilieu around implants, resulting in the critical implantation failure and high complications such as peri-implantitis and angiectasis disorder. To address the plaguing issue, we devise and develop a glucose-unlocked NO-evolving orthopedic implant consisted of polyetheretherketone (PEEK), glucose oxidase (GOx) and l-arginine (Arg) with enhanced angiogenesis for boosting diabetic osseointegration. Upon hyperglycemic niche, GOx on implants catalytically exhaust glucose to H2O2, which immediately reacts with Arg to in situ liberate nitric oxide (NO), resulting in enhanced angiogenesis and angiectasis around PEEK implant. Besides, the engineered implant exhibits great anti-bacterial properties against both Gram-positive and Gram-negative bacteria, as well as fortifies osteogenicity of osteoblasts in terms of cell proliferation, alkaline phosphatase activity and calcium matrix mineralization. Intriguingly, in vivo evaluations utilizing diabetic infectious bone defect models of rat further authenticate that the engineered implants substantially augment bone remodeling and osseointegration at weeks 4 and 8 through dampening pathogens, anti-inflammatory as well as promoting angiectasis. Altogether, this work proposed a new tactic to remedy stalled diabetic osseointegration with hyperglycemic micromilieu-responsive therapeutic gas-evolving orthopedic implants.

Ultrasound-activated sonothermal-catalytic synergistic therapy via asymmetric electron distribution for bacterial wound infections

Antibiotic-resistant bacterial infections present a growing global health challenge, requiring innovative therapeutic solutions to overcome current limitations. We introduce boron-integrated bismuth oxide (B-BiO2) nanosheets with an asymmetrically distributed electronic structure for ultrasound-activated synergistic sonothermal and catalytic therapy. Boron incorporation enhances local electron density distribution, optimizing charge separation and significantly improving sonothermal and catalytic efficiency, as validated by density functional theory calculations. These nanosheets exhibit dual functionality, effectively generating localized heat and reactive oxygen species (ROS) under ultrasound, leading to 99.999 % antibacterial efficacy against multidrug-resistant pathogens by disrupting bacterial membranes, as demonstrated through all-atom simulations and in vitro experiments. The simulations further reveal that sonothermal conversion effects enhance bacterial membrane fluidity and induce structural defects, amplifying ROS-induced oxidative damage and membrane destabilization. In vivo, B-BiO2 nanosheets accelerate wound healing in methicillin-resistant Staphylococcus aureus (MRSA)-infected murine models, achieving 99.8 % closure by day 14 by reducing inflammation and promoting angiogenesis and tissue regeneration. Transcriptomic analysis highlights the activation of extracellular matrix remodeling, angiogenesis, and autophagy pathways, underscoring the nanosheets' therapeutic potential. This study establishes ultrasound-activated B-BiO2 nanosheets as a novel nanotherapeutic platform, leveraging asymmetric electron distribution to synergistically combat drug-resistant infections and promote effective wound healing.

Time-resolved T1 and T2 contrast for enhanced accuracy in MRI tumor detection

Stimuli-responsive contrast agents (CAs) have shown great promise in enhancing magnetic resonance imaging (MRI) for more accurate tumor diagnosis. However, current CAs still face challenges in achieving high accuracy due to their low specificity and contrast signals being confounded by potential endogenous MRI artifacts. Herein, an extremely small iron oxide nanoparticle (ESIONP)-based smart responsive MRI contrast agent (LESPH) is proposed, which is meticulously designed with sequential dual biochemical stimuli-initiated, time-resolved T1 and T2 contrast presentation, ensuring high tumor specificity while minimizing interference from endogenous artifacts. LESPH is constructed using emulsion solvent evaporation by assembling poly(2-(hexamethyleneimino) ethyl methacrylate) terminally conjugated with a disulfide bond-linked catechol group (DSPH)-modified ESIONPs, with lauryl betaine serving as a surfactant. When LESPH undergoes sequential responses to the weak acidity and high-concentration glutathione (GSH) in the tumor microenvironment, it experiences an extremely rapid transition from sparse ESIONP assemblies to dispersed ESIONPs, followed by a slower transition to closely aggregated ones, concomitantly providing distinguishable brightening and darkening contrast enhancement at the tumor location on different time scales. By virtue of its sequential dual responsiveness and time-resolved distinguishable contrast enhancements, LESPH successfully detects tumors with extremely high accuracy, providing a novel paradigm for the precise medical diagnosis of cancer.

Immunomodulatory bioadhesive technologies

Bioadhesives have found significant use in medicine and engineering, particularly for wound care, tissue engineering, and surgical applications. Compared to traditional wound closure methods such as sutures and staples, bioadhesives offer advantages, including reduced tissue damage, enhanced healing, and ease of implementation. Recent progress highlights the synergy of bioadhesives and immunoengineering strategies, leading to immunomodulatory bioadhesives capable of modulating immune responses at local sites where bioadhesives are applied. They foster favorable therapeutic outcomes such as reduced inflammation in wounds and implants or enhanced local immune responses to improve cancer therapy efficacy. The dual functionalities of bioadhesion and immunomodulation benefit wound management, tissue regeneration, implantable medical devices, and post-surgical cancer management. This review delves into the interplay between bioadhesion and immunomodulation, highlighting the mechanobiological coupling involved. Key areas of focus include the modulation of immune responses through chemical and physical strategies, as well as the application of these bioadhesives in wound healing and cancer treatment. Discussed are remaining challenges such as achieving long-term stability and effectiveness, necessitating further research to fully harness the clinical potential of immunomodulatory bioadhesives.

Nanomaterial technologies for precision diagnosis and treatment of brain hemorrhage

Brain hemorrhage events present complex clinical challenges due to their rapid progression and the intricate interplay of oxidative stress, inflammation, and neuronal damage. Traditional diagnostic and therapeutic approaches often struggle to meet the demands for timely and effective intervention. This review explores the cutting-edge role of nanomaterials in transforming cerebral hemorrhage management, focusing on both diagnostic and therapeutic advancements. Nanomaterial-enabled imaging techniques, such as optical imaging, magnetic resonance imaging, and magnetic particle imaging, significantly enhance the accuracy of hemorrhage detection by providing real-time, high-resolution assessments of blood-brain barrier (BBB) integrity, cerebral perfusion, and hemorrhage progression, which is critical for guiding intervention strategies. On the therapeutic front, nanomaterial-based systems enable the precise delivery of drugs and bioactive molecules, fostering neural repair and functional recovery while minimizing systemic side effects. Furthermore, multifunctional nanomaterials not only address the primary injury but also offer precise control over secondary injuries, such as edema and oxidative stress. Their ability to enhance neuroprotection, prevent re-bleeding, and stimulate brain tissue regeneration provides a holistic approach and marks a significant advancement in brain hemorrhage therapy. As the field continues to advance, nanotechnology is set to fundamentally reshape the clinical management and long-term outcomes of brain hemorrhages, presenting a paradigm shift towards personalized and highly effective neurological care.

Rational design of dual-state emission fluorophores for sensing nitro explosives by using sulfone unit as an electron acceptor in D-A system

Dual-state emission (DSE) fluorescent molecules have become the preferred type in designing sensing fluorescent molecules due to the virtue of their bright emission in both solid and liquid states. In this study, five D-A molecules were successfully designed and synthesized according to the design concept that structural modification of D-A molecules can lead to DSE molecules. Among them, the balance between the electron donor with a strong electron donation capacity and the twisted conformation in the whole molecule makes the compounds 3c-3e DSE molecules with excellent optical performances, showing significant solvatochromic effects and large Stoke shifts. In addition, the feasibility of the sulfone unit as an electron acceptor in the D-A structure is also verified, extending the application of sulfone group in the field of fluorescence. Interestingly, the fluorescence of 3c can exhibit sensitive and selective quenching of nitro aromatic compounds (NACs) under the synergistic mechanism of fluorescence resonance energy transfer (FRET) and photoinduced electron transfer (PET), with LOD as low as 10-8 M and KSV as high as 104 M-1. Furthermore, the selective, efficient, and sensitive detection of NACs by DSE fluorescent molecule 3c in real aqueous samples and loaded on test strips has demonstrated the potential of its practical applications.

Ratiometric fluorescent probe for triphosgene detection and its application in electrospun fluorescent fibers

Triphosgene poses a potentially great threat to human health and safety. Therefore, it is of great significance to develop an effective method to realize the inexpensive, on-site, convenient, and rapid detection of triphosgene. Herein, based on the excited-state intramolecular proton transfer mechanism, a new fluorescent probe DPIM was designed and synthesized, which realized the rapid ratiometric identification and detection of triphosgene for the first time. Its limit of detection for triphosgene was 3.54 × 10-8 M, and it had a large Stokes shift of 198 nm. Its recognition mechanism was comprehensively analyzed. A smartphone detection platform and probe-loaded test paper were prepared to realize the inexpensive, on-site, and convenient detection of triphosgene. DPIM effectively enabled the ratiometric fluorescence "turn-on" for detecting residual triphosgene in the sand, showing its application practicality. Most importantly, the probe was incorporated into nanofibers and successfully used to monitor gaseous triphosgene with high specificity, showing its excellent application potential. This study provides a promising analytical tool for the rapid quantitative detection of triphosgene in solution and gaseous phases.

A smart photosensitive fluorescent probe for sensing Co2+ in extremely alkaline aqueous solution

A novel pH-, viscosity-, and photo-sensitive polymorphic fluorescence probe NHP for sensing Co2+ has been developed. The hydrazone-based NHP can be synthesized by only one step of reflux reaction and purified by washing with poor solvents. Three single crystals of NHP-1, NHP-2, and NHP-3 with different conformations were resolved. As a photo acid generator (PAG), the hydrogen atom on the imino group of the probe NHP can be shed with 365 nm ultraviolet (UV) light illumination or in alkaline conditions. Due to the above two conditions, the negatively charged ligand obtained after dehydrogenation of NHP can accelerate its chelation with Co2+. When irradiated with 365 nm UV light, the product (NHP2-Co2+ (I)) of NHP chelating with Co2+ appears yellowish in aqueous solution. In a strong alkali aqueous solution, the chelate product (NHP2-Co2+ (II)) of NHP and Co2+ showed bright blue-green fluorescence. The formed divalent Co(II) complex NHP2-Co2+ can be oxidized to trivalent Co(III) complex NHP3-Co3+, as confirmed by the resolution of single crystals of NHP3-Co3+.

Small Au nanoparticles to be modified with decavanadate for sensitive and stable SERS detection

Surface enhanced Raman spectroscopy (SERS) has been a powerful vibrational optical spectroscopic technique for trace determination. And the application and promotion of SERS technology are closely related to plasmonic substrates. To combine the distinct electronic properties of polyoxovanadates with the plasmonic properties of Au NPs, the small cit-Au NPs (reduced by sodium citrate) was modified with decavanadate (V10) via ligand displacement. The structure of V10 was controlled by pH adjustment. X-ray photoelectron spectroscopy (XPS) and SERS were introduced for studying interactions of V10 with the surface of Au NPs. Compared with cit-Au NPs, V10-Au NPs owned higher absolute value of zeta potential and presented greater stability in CH3OH/H2O (V/V = 1:10) solvent environment. Even after 60 min of soaking, the V10-Au NPs still exhibited a typical coffee ring effect during the evaporation process with SERS enhancement. The stability of V10-Au NPs (in a solution with pH 4.8) was tested over a period of 5 days to indicate their ability to maintain SERS activity. Moreover, the V10-Au NPs also showed great sensitivity for cationic dye molecules and antibiotics, and the detection levels could be as low as μg⋅L-1. This study lays the foundation for the screening low-concentration cations in mixed solutions and monitoring the morphological changes of polyoxometalates during their application via SERS technology.

Molybdoenzymes-emulating bio-heterojunction hydrogel with rapid disinfection and macrophage reprogramming for wound regeneration

Developing hydrogel dressings with the capabilities to accommodate irregular wounds and provide a cascade disinfective-regenerative microenvironment for wound repair is of great importance to combating pathogenic bacteria-infected wounds but remains an ongoing challenge. To address the conundrum, we devise a molybdoenzymes-emulating bio-heterojunction (M-bioHJ) doped double network (DN) hydrogel dressing for bacterial-infected wound healing. The near-infrared (NIR) photothermal effect of the M-bioHJ facilitates the exchange of multiple dynamic crosslinking sites in the hydrogel, endowing the hydrogel with photo-remote reprocessing capabilities to completely accommodate the encountered irregular wounds and ultimately accomplish the admirable therapeutic effect. Meanwhile, the introduced M-bioHJ shows NIR light-enhanced photodynamic activity to induce a massive engendering of reactive oxygen species (ROS), allowing rapid sterilization without reliance on exogenous hydrogen peroxide. Furthermore, the Mo ions released from the M-bioHJ-encapsulated hydrogel can play a crucial role in reprogramming the macrophage phenotype and determining tissue regeneration. Both in vitro and in vivo evidences authenticate the accelerated healing potential of infected wounds through the synergistic effects of photo-reprocessing, disinfection, and macrophage-reprogramming facilitated by the hydrogel. These findings highlight the promising application prospects of such neoteric M-bioHJ-encapsulated hydrogel dressings for wound disinfection and tissue regeneration.

A PEG-based strategy to improve detection of clinical microRNA 155 by bio-Field Effect Transistor in high ionic strength environment

microRNAs are small oligonucleotides involved in post-transcriptional gene regulation whose alteration is found in several diseases, including cancer, and therefore their detection is crucial for diagnosis, prognosis, and treatment purposes. Field-Effect Transistor-based biosensors (bioFETs) represent a promising technology for the clinical detection of microRNAs. However, one of the main challenges associated with this technology is the Debye screening, becoming significant at the high ionic strengths required for effective hybridization. We aimed at detecting oncogenic microRNA-155 by using a bioFET system using as capture element a complementary RNA probe (antimiR-155) combined with the introduction of PEG molecules (20 kDa, PEG20), at an ionic strength of 300 mM. We optimized the co-immobilization ratio between antimiR-155 and PEG20 and assessed its impact on the interactions between the oligonucleotides. The kinetics can be well described by the Langmuir-Freundlich isotherm with an affinity constant within the range typical of nucleic acid interactions. The introduction of PEG20 significantly enhanced the detection sensitivity of miR-155 by reaching a level of less than 200 pM, together with excellent discrimination against other clinically relevant microRNAs. Our findings demonstrate that the incorporation of PEG20 constitutes an effective strategy to mitigate the Debye screening effects and facilitates bioFET-based clinical applications at physiological ionic strengths.

Acid and phosphatase-triggered release and trapping of a prodrug on cancer cell enhance its chemotherapy

Using anticancer drug-encapsulated nanocarriers to actively target tumors is a promising chemotherapy strategy. Nevertheless, premature release of the drugs in tumor microenvironment (TME) or low tumor targeting efficiency of the nanocarriers significantly reduces its therapeutic efficiency. Herein, we propose a release-and-trapping strategy that significantly enhances the chemotherapeutic efficiency of an anticancer drug camptothecin. TME acid triggers the release of its prodrug from the nanocarrier and thereafter phosphatase instructs the prodrug to form hydrogel to trap the nanocarrier on cancer cell membrane. As trapped nanocarrier facilitates cell uptake of the prodrug and its intracellular carboxylesterase-mediated hydrolysis to release camptothecin. In vitro studies showed that the prodrug release from nanocarrier was maximized at pH 6.5. In tumor-bearing mice, our release-and-trapping strategy significantly prolonged the retention of the nanocarrier in tumor and significantly enhanced the anticancer efficacy of camptothecin. We propose that our release-and-trapping strategy be applied for more efficient cancer treatment in the future.

Band gap regulation of MIL-101(Fe) via pyrazine-based ligands substitution for enhanced visible-light adsorption and its photo-Fenton-like application

Regulating the photo-response region of iron metal-organic frameworks (Fe-MOFs) is a viable strategy for enhancing their practical application in the visible-light driven photo-Fenton-like process. This study developed a novel pyrazine-based Fe-MOFs (MIL-101(Fe)-Pz) by substituting the 1,4-dicarboxybenzene acid ligands in typical MIL-101(Fe) with 2,5-pyrazinedicarboxylic acid (PzDC), in which sodium acetate was used as coordinative modulator to control the crystal size (2-3 µm). The incorporation of Fe-pyridine N coordination structures originated from PzDC ligands gave MIL-101(Fe)-Pz narrowed band gap (1.45 eV) than MIL-101(Fe) (2.54 eV) resulting in improved visible-light adsorption capacity (λ > 420 nm), and also increased the proportion of Fe(II) in the Fe-clusters. Thus MIL-101(Fe)-Pz exhibited a synergistic enhanced photo-Fenton-like catalytic performance under visible-light irradiation. The MIL-101(Fe)-Pz/H2O2/Vis system could degrade 99% of sulfamethoxazole within 30 min, which was 10-fold faster than that of the pristine MIL-101(Fe), it also effectively removed other organic micropollutants with high durability and stability. Mechanistic analysis revealed that the PzDC ligands substitution decreased the band gap of MIL-101(Fe), giving MIL-101(Fe)-Pz appropriate band structure (-0.40∼1.05 V vs. NHE) which can cover several light-driven process for the generation of reactive oxygen species, including Fe(III) reduction and H2O2 activation for accelerating •OH generation, as well as oxygen reduction reaction for generating H2O2, O2•- and 1O2. This study highlights the role of pyridine-N containing ligands in regulating the band structure of Fe-MOFs, providing valuable guidance for the design of Fe-MOFs photocatalysts.

Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury-related Alzheimer's disease

Traumatic brain injury and Alzheimer's disease share pathological similarities, including neuronal loss, amyloid-β deposition, tau hyperphosphorylation, blood-brain barrier dysfunction, neuroinflammation, and cognitive deficits. Furthermore, traumatic brain injury can exacerbate Alzheimer's disease-like pathologies, potentially leading to the development of Alzheimer's disease. Nanocarriers offer a potential solution by facilitating the delivery of small interfering RNAs across the blood-brain barrier for the targeted silencing of key pathological genes implicated in traumatic brain injury and Alzheimer's disease. Unlike traditional approaches to neuroregeneration, this is a molecular-targeted strategy, thus avoiding non-specific drug actions. This review focuses on the use of nanocarrier systems for the efficient and precise delivery of siRNAs, discussing the advantages, challenges, and future directions. In principle, siRNAs have the potential to target all genes and non-targetable proteins, holding significant promise for treating various diseases. Among the various therapeutic approaches currently available for neurological diseases, siRNA gene silencing can precisely "turn off" the expression of any gene at the genetic level, thus radically inhibiting disease progression; however, a significant challenge lies in delivering siRNAs across the blood-brain barrier. Nanoparticles have received increasing attention as an innovative drug delivery tool for the treatment of brain diseases. They are considered a potential therapeutic strategy with the advantages of being able to cross the blood-brain barrier, targeted drug delivery, enhanced drug stability, and multifunctional therapy. The use of nanoparticles to deliver specific modified siRNAs to the injured brain is gradually being recognized as a feasible and effective approach. Although this strategy is still in the preclinical exploration stage, it is expected to achieve clinical translation in the future, creating a new field of molecular targeted therapy and precision medicine for the treatment of Alzheimer's disease associated with traumatic brain injury.

Nitrogen mono-doping of graphene and co-doping with group 14 as a sensor for diisobutyl phthalate: Insight from a computational study

Diisobutyl phthalate (DIBP) is a highly toxic plasticizer found in edible consumer products and industrial products. It affects the male reproductive system, bioaccumulates in water, and poses health risks. Given its widespread occurrence, designing novel sensor materials for sensing of DIBP is necessary for environmental and health safety. In this research, density functional theory (DFT) at the DFT/MN15/LanL2DZ level was employed to study the structural analysis, electronic properties, visual studies, and sensor mechanisms of modified graphene systems for the detection of diisobutyl pththalate (DIBP). An increase in energy gap values was observed for all studied systems on complexation with gas molecules, which depicted the stable properties of the system. The electronic properties revealed that upon adsorption, the DIBP-Sn-N@GP energy gap was the smallest at 2.778 eV, which indicates great conductivity. The adsorption energy showed that chemisorption occurred in the studied systems. DIBP-Si-N@GP showed the strongest adsorption energy of -18.171 eV, while DIBP-N@GP showed weak chemisorption of -0.914 eV. According to the UV-visible spectrum, DIBP-Ge-N@GP has the greatest peak at a wavelength of 1979.79 nm in the first excited state, corresponding to the H-1→L+2 transition. The sensor mechanism showed that among the tested surfaces, DIBP-Si-N@GP showed the best sensing properties and can be considered good gas sensor materials, attributed to its highest adsorption energy, stabilization energy, and charge transfer values with the lowest back donation energy value.

Ultrasound-switchable piezoelectric BiVO4/fullerene heterostructure for on-demand ROS modulation in MRSA-infected diabetic wound healing

Persistent microbial infections and excessive reactive oxygen species (ROS) accumulation severely impede diabetic wound healing. Herein, we developed an ultrasound-switchable BiVO4/fullerene piezoelectric heterostructure via a one-pot solvothermal method, enabling on-demand transition between bactericidal action and ROS scavenging for treating infected diabetic wounds. Under 8-min ultrasound (US) irradiation, the heterojunction sonosensitizer leveraged piezoelectric polarization to generate substantial ROS in real-time through a narrowed energy band gap and enhanced charge carrier separation and migration efficiency, resulting in the disruption of bacterial membrane integrity and 99.9 % eradication of methicillin-resistant Staphylococcus aureus (MRSA). Upon US withdrawal, the sonosensitizer spontaneously transitioned to an antioxidative state through fullerene-mediated ROS scavenging, effectively neutralizing excess ROS and restoring cellular redox balance. In an MRSA-infected diabetic wound model, this ultrasound-responsive duality effectively suppressed bacterial proliferation, reduced inflammation, enhanced angiogenesis, and ultimately accelerated wound healing within 14 days. This ultrasound-switchable therapeutic strategy offers promising insights for managing drug-resistant infections and other ROS-mediated biomedical challenges.

Development of an electroconductive Heart-on-a-chip model to investigate cellular and molecular response of human cardiac tissue to gold nanomaterials

To date, various strategies have been developed to construct biomimetic and functional in vitro cardiac tissue models utilizing human induced pluripotent stem cells (hiPSCs). Among these approaches, microfluidic-based Heart-on-a-chip (HOC) models are promising, as they enable the engineering of miniaturized, physiologically relevant in vitro cardiac tissues with precise control over cellular constituents and tissue architecture. Despite significant advancements, previously reported HOC models often lack the electroconductivity features of the native human myocardium. In this study, we developed a 3D electroconductive HOC (referred to as eHOC) model through the co-culture of isogenic hiPSC-derived cardiomyocytes (hiCMs) and cardiac fibroblasts (hiCFs), embedded within an electroconductive hydrogel scaffold in a microfluidic-based chip system. Functional and gene expression analyses demonstrated that, compared to non-conductive HOC, the eHOC model exhibited enhanced contractile functionality, improved calcium transients, and increased expression of structural and calcium handling genes. The eHOC model was further leveraged to investigate the underlying electroconduction-induced pathway(s) associated with cardiac tissue development through single-cell RNA sequencing (scRNA-seq). Notably, scRNA-seq analyses revealed a significant downregulation of a set of cardiac genes, associated with the fetal stage of heart development, as well as upregulation of sarcomere- and conduction-related genes within the eHOC model. Additionally, upregulation of the cardiac muscle contraction and motor protein pathways were observed in the eHOC model, consistent with enhanced contractile functionality of the engineered cardiac tissues. Comparison of scRNA-seq data from the 3D eHOC model with published datasets of adult human hearts demonstrated a similar expression pattern of fetal- and adult-like cardiac genes. Overall, this study provides a unique eHOC model with improved biomimcry and organotypic features, which could be potentially used for drug testing and discovery, as well as disease modeling applications.

A novel hypochlorous acid-activated NIR fluorescent probe with a large Stokes shift for bioimaging and early diagnosis of arthritis

In this work, we synthesized a novel hypochlorous acid-activated near-infrared (NIR) fluorescent probe (RhSBZ) by a strategy of enhancing π-conjugation through modification the 3,6-substituents of xanthene. Specifically designed for HClO bioimaging and arthritis diagnosis, RhSBZ displayed exceptional performance. RhSBZ exhibited a Stokes shift of 148 nm, high sensitivity, excellent selectivity, and a detection limit as low as 4.95 nM for HClO. Especially, upon reaction with HClO, the fluorescence intensity of RhSBZ enhanced dramatically by 61-fold. Notably, RhSBZ not only can detect exogenous and endogenous HClO in MCF-7 cells, but also has impressive imaging depth of up to 140 μm in rat liver tissues. More encouragingly, RhSBZ can be successfully used for the early diagnosis of abdominal inflammation and arthritis in mice. In summary, RhSBZ displayed excellent bioimaging capabilities and will have the potential application in the early diagnosis of inflammation diseases.

Manganese-based virus-mimicking nanomedicine with triple immunomodulatory functions inhibits breast cancer brain metastasis

Hindered by the challenges of blood-brain barrier (BBB) hindrance, tumor heterogeneity and immunosuppressive microenvironment, patients with breast cancer brain metastasis have yet to benefit from current clinical treatments, experiencing instead a decline in quality of life due to radiochemotherapy. While virus-mimicking nanosystems (VMN) mimicking viral infection processes show promise in treating peripheral tumors, the inability to modulate the immunosuppressive microenvironment limits the efficacy against brain metastasis. Accordingly, a VMN-based triple immunomodulatory strategy is initially proposed, aiming to activate innate and adaptive immune responses and reverse the immunosuppressive microenvironment. Here, manganese-based virus-mimicking nanomedicine (Vir-HD@HM) with intratumoral drug enrichment is engineered. Vir-HD@HM can induce the immune response through the activation of cGAS-STING by mimicking the in vivo infection process of herpesviruses. Meanwhile, DNAzyme mimicking the genome can rescue the epigenetic silencing of PTEN with the assistance of Mn2+, thus ameliorating the immunosuppressive metastatic microenvironment and achieving synergistic sensitizing therapeutic efficacy. In vivo experiments substantiate the efficacy of Vir-HD@HM in recruiting NK cells and CD8+ T cells to metastatic foci, inhibiting Treg cells infiltration, and prolonging murine survival without adjunctive radiochemotherapy. This study demonstrates that Vir-HD@HM with triple immunomodulation offers an encouraging therapeutic option for patients with brain metastasis.

A new HBT-quinolinium platform for optical detection of biogenic amines and its application in food quality monitoring

Biogenic amines (BAs) are critical biomolecules that play key roles in physiological processes and serve as important indicators in food safety, clinical diagnostics, and environmental monitoring. Therefore, sensitive, selective, and rapid tools are required for BA detection. This study explores the synthesis and applications of a new fluorescent probe (DBQ) for detecting BAs, focusing on their fluorescence response mechanisms. DBQ offers a promising alternative due to its high selectivity, sharp color change, low detection limit (0.057 μM for cadaverine), long lifetime (τ ≈ 2.40 ns), rapid response (15 min), low cytotoxicity (over 90 % cell viability in the presence of 10.0 μM of DBQ) and favorable photophysical properties, including large Stokes shift (213 nm in CHCl3). In addition, DBQ displays solvent-dependent intramolecular charge transfer (ICT), resulting in solvatochromism. The developed smartphone sensing system was applied to the detection of BAs. The developed sensing test kit responds quickly to the presence of volatile biogenic amines, with notable visible response and high selectivity. In on-site analysis, we were able to successfully use these test strips for non-destructive evaluation of chicken and cheese freshness with the use of a smartphone. Therefore, the current study will contribute to improving food safety and reduce food loss and waste by developing new bioanalytical technologies that offer chemical information about the composition of food, which is extremely valuable for enhancing traceability and extending food shelf life.

Aggregation-induced emission-based aptasensors for the detection of various targets: Recent progress

The advancement of aptasensors utilizing aggregation-induced emission (AIE) has progressed remarkably in recent years, owing to various unique benefits provided by aggregation-induced emission luminogens (AIEgens) as a novel category of fluorescent substances and aptamers as exceptional recognition components. AIE refers to a photophysical phenomenon identified in certain luminogens that show minimal or absent emission in dilute solutions, yet display considerable emission when in aggregate or solid states. Fluorescent sensing is an effective technique for the detection of various targets; however, many traditional dyes frequently demonstrate an aggregation-caused quenching (ACQ) effect in solid form, which limits their applicability on a larger scale. In contrast, fluorescent probes that leverage AIE characteristics have garnered considerable interest, owing to their elevated fluorescence quantum yields and ease of fabrication. This review discusses the application of various AIEgens in the design of diverse sensitive and selective AIE-based aptasensors for monitoring various targets, with a particular focus on recent advances. The AIE-based aptasensors exploit the supreme affinity of the aptamers to their targets and the remarkable properties of AIEgen, including its photostability and high quantum yield, and the interaction between AIEgen and DNA. The objective is to acquaint researchers with the various categories of materials exhibiting AIE characteristics and their potential applications in the creation of different aptasensors, enabling them to introduce novel kinds of innovative AIEgens and AIE-integrated aptasensors.

Morphological advances and innovations in conjugated polymer films for high-performance gas sensors

Conjugated polymers (CPs) are considered one of the most important gas-sensing materials due to their unique features, combining the benefits of both metals and semiconductors, along with their outstanding mechanical properties and excellent processability. However, CPs with conventional morphological structures, such as largely amorphous and bulky matrices, face limitations in practical applications because of their inferior charge transport characteristics, low surface area, and insufficient sensitivity. Therefore, the design and development of novel morphological nanostructures in CPs have attracted significant attention as a promising strategy for improving morphological and electrical characteristics, thereby enabling a considerable increase in the sensing performance of corresponding gas sensors. Numerous CP nanostructures have been developed and implemented for high-performance gas sensors. Highlighting the morphological advances and bottlenecks of these nanostructures is crucial for providing an overview of developing trends, potential strategies, and emerging areas for the future development of CP nanostructures in the field. In this regard, this study describes state-of-the-art CP nanostructures, emphasizing their attractive morphological and electrical characteristics to help readers and researchers better understand emerging trends, promising future directions, and key obstacles for the application of CP nanostructure-based gas sensors. The most crucial aspects of CP nanostructures, including advanced preparation techniques, morphological properties, and sensing characteristics, are discussed and assessed in detail. Moreover, development strategies and perspectives for achieving high sensing efficiency in CP nanostructure-based flexible and wearable sensors are summarized and emphasized.

Vacancies-rich Z-scheme VdW heterojunction as H2S-sensitized synergistic therapeutic nanoplatform against refractory biofilm infections

Encapsulated in a self-produced negatively charged extracellular polymeric substance (EPS) matrix, the wound infected bacterial biofilms exhibit formidable resistance to conventional positively charged antibiotics and host's immune responses, which can undoubtedly lead to persistent infections and lethal complications. Nevertheless, developing efficacious strategies to root out stubborn biofilm and promote tissue regeneration still remains a challenge. To resolve this dilemma, a versatile vacancies-rich Z-scheme MoSSe Van der Waals heterojunction (MoSSe VdW HJ) is rationally fabricated as nanoplatform for hydrogen sulfide (H2S)-sensitized synergistic therapy of wound bacterial biofilm infection. The rich anion vacancies and Z-scheme heterostructure make the fabricated MoSSe VdW HJ can effectively augment H2S, localized hyperthermia, and reactive oxygen species production under the stimulation of biofilm microenvironments (BME) and irradiation of 808 nm near-infrared (NIR) light. Therefore, MoSSe VdW HJ is capable to integrate H2S gas, chemodynamic, photothermal, and photodynamic therapies to effectively destroy eDNA and polysaccharides in the EPS matrix, thereby breaching the biofilm barrier to eradicate bacteria and facilitate wound healing. The synergistic strategy exhibits superior anti-biofilm and wound repair effects both in vivo and in vitro, thus providing guideline for the development of BME and NIR light activated synergistic therapeutics to fight against refractory biofilm infections.

Multi-target analysis of synthetic phenolic compounds in human blood

Synthetic phenolic compounds are widely used in plastics and personal care products, leading to potential high human exposure. This study aimed to develop two multi-target analytical methods to quantify phenolic compounds in human serum, including free and conjugated synthetic phenolic antioxidants (SPAs), bisphenols, parabens, and UV filters. The two methods were applied to 30 human serum samples from young adults (15 females and 15 males) living in Stockholm, Sweden. An average recovery of 73 % (range 36-125 %) and good reproducibility (RSD <30 %) were established for 37 target analytes, and another four analytes were semi-quantified. Twenty-one target analytes were found above quantification levels. Notable, five SPAs, namely 2,2'-methylenebis(4-methyl-6-tert-butylphenol) (AO2246), 4,4'-methylenebis(2,6-di-tert-butylphenol) (AO4426), 4-tert octylphenol (4-tOP), butylade hydroxyanisole (BHA), butylated hydroxytoluene (BHT) were quantified in >93 % of samples, and with median concentrations between 1.4 (BHA) and 520 ng/g (AO2246). Other compounds quantified in the samples were bisphenol B (quantification frequency 57 %) and methylparaben (quantification frequency 87 %), with median concentrations of 0.38 and 1.6 ng/g respectively. Additionally, two features were semi-quantified using suspect screening: Fenozan (an SPA metabolite, 3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid) and benzophenone-4 (a UV filter, 5-benzoyl-4-hydroxy-2-methoxybenzenesulfonic acid). To the best of our knowledge, this is the first time AO4426, 3,5-di-tert-butyl-4-hydroxybenzoic acid (BHT-COOH), 2-tert-butylbenzene-1,4-diol (TBHQ), bisphenol B, and Fenozan have been found in human blood. The finding of SPAs in human blood indicates high human exposure and needs further investigation.

A new perspective on antimicrobial therapeutic drug monitoring: Surface-enhanced Raman spectroscopy

Therapeutic drug monitoring (TDM) enables the personalization of treatment regimens, enhancing efficacy in combating infectious diseases while minimizing toxicity risks and reducing the potential for pathogenic resistance. However, existing TDM techniques still present certain limitations. Chromatographic analysis involves a prolonged detection period, which hampers its capacity for rapid multi-sample analysis. Immunoassay is constrained by poor specificity and stability, as well as a restricted range of detectable drugs. Surface-enhanced Raman spectroscopy (SERS) amplifies the Raman signals of target molecules via the local electromagnetic field and charge transfer effects on the surface of plasmonic materials, offering many significant advantages including high sensitivity, rapid detection, minimal sample requirements, and the ability to provide molecular fingerprints. SERS biosensing has demonstrated considerable potential in the field of blood drug concentration monitoring. This paper comprehensively reviews the research on the application of SERS in the TDM of antimicrobial agents. Beginning with the clinical practice of antimicrobial TDM, this review systematically introduces the principles of SERS techniques, the enhancement substrates, and the commonly used data processing methods including machine learning. It then provides a detailed discussion of the application of SERS in the TDM of various types of antimicrobials. Finally, it summarizes four major challenges currently faced by SERS techniques in antimicrobial TDM-namely protein corona effects, matrix interferences, substrate heterogeneity, and quantification reproducibility-and proposes potential future directions. This paper aims to offer new strategies and perspectives for the TDM and personalized dosage of antimicrobial agents.

A new β-amylase detection strategy based on encapsulated enzyme in magnetic layered double hydroxide with high sensitivity and simplified workflow

β-Amylase (BMY) is a linchpin in food production and the pharmaceutical industry because the enzyme efficiently controls the ratio of diverse saccharides in fermentation and the manufacture of high-quality maltose. However, existing BMY detection tactics suffer from inadequate selectivity/sensitivity and cumbersome operation and do not meet the needs of precise quantification. Consequently, there is an urgent need to develop an ultrasensitive sensing platform to achieve precise BMY analysis with a low detection limit and simpler workflow. In this work, we establish an encapsulated-enzyme-based BMY biosensing platform in which α-glucosidase is embedded in magnetic layered double hydroxide using a self-sacrificing template. The encapsulated enzyme has increased activity, robustness, and recyclability and was utilized for BMY detection via a cascade chromatic process. We found a detection limit for the quantification of BMY activity of 2.67 U/L with a broad range (5-400 U/L), fast response speed (10 min), and satisfactory specificity. We applied the biosensing platform to liquor starters to verify the capability of the assay in complicated fermentation samples. The proposed platform holds great promise as an efficient and simple method for enzymatic bioactivity monitoring in food manufacturing, biopharmaceutical processing, and clinical laboratory tests.

Target-induced reconstruction of Ru(bpy)32+-loaded gold nanocage for one-step highly sensitive detection of Hg2

In this work, Ru(bpy)32+-loaded gold nanocage (AuNCs) (Ru-AuNCs) was prepared and found to display a distinct property of electrochemiluminescence (ECL) enhancement under mercury ions (Hg2+) interaction. Based on this, we designed a screen-printed bipolar electrode-ECL (SPBPE-ECL) sensing platform by coupling with the thymine-Hg2+-thymine (T-Hg2+-T) binding pattern for one-step highly sensitive detection of Hg2+. This ECL sensor showed a wide linear detection range (0.75 - 850 μg L-1) and low detection limit (0.1290 μg L-1) toward Hg2+, with a one-step detection procedure and disposable feature, displaying potential applicability in the point-of-care-testing (POCT) of Hg2+ in the environment. In addition, the Hg2+-mediated ECL signal enhancement mechanism of Ru-AuNCs was also investigated. It was confirmed that Hg2+ interaction etched the cage structure of Ru-AuNCs, which sped up the release of more Ru(bpy)32+ around the sensing electrode. Furthermore, Au-Hg alloy structure was formed on the surface of Ru-AuNCs, which also improved the ECL signal. This target-induced in-situ sensing material surface reconstruction strategy would provide a better design concept for the construction of ECL POCT sensor.

Domino-like turn-on chemiluminescence amplification: Opening a gateway through proximal-imidazole species formation and metal-ligand complexation

Due to their extremely low background signal and high sensitivity, the chemiluminescence (CL) probes have received a great attention in various chemical and biological applications. However, the lack of selectivity is still a challenging task. As an innovative topic of research, in this work we developed a domino-like turn-on CL reaction through proximal-imidazole species for the first time. The oxidation reaction of N-(2H-[1,2,4]thiadiazolo[2,3-a]pyridine-2-ylidene)benzamide (1) by hydrogen peroxide found to promoted by a domino-like reaction between proximal imidazole species and the Co2+-1 complex formation which accompanied by a dramatically turn-on emission. In the way of explaining the possible mechanism, the application of density functional theory (DFT) studies revealed that there are three possible pathways for the reactions between precursor 1 and HOO- in the presence of imidazole to produce the oxidized isomers. The strongest interaction found to occur in pathway 3, in which the sulfur atom was oxidized, while there was some repulsion between HOO- and 1, due to the effects of two different charges in pathways 1 and 2. To confirm tits applicability, the CL system was successfully applied to highly selective quantification of vitamin B12 in some real samples. The linear dynamic range was achieved from 0.08 to 34 ng mL-1 and the detection limit was evaluated as 0.028 ng mL-1. This new method introduced fluorescence selectivity and CL sensitivity in single technique. It was finally anticipated that the CL amplification through proximal-imidazole species possesses a great potential on tuning various color-emissions based on different metal-ligand complex formations studied.

Force-electric biomaterials and devices for regenerative medicine

There is a growing recognition that force-electric conversion biomaterials and devices can convert mechanical energy into electrical energy without an external power source, thus potentially revolutionizing the use of electrical stimulation in the biomedical field. Based on this, this review explores the application of force-electric biomaterials and devices in the field of regenerative medicine. The article focuses on piezoelectric biomaterials, piezoelectric devices and triboelectric devices, detailing their categorization, mechanisms of electrical generation and methods of improving electrical output performance. Subsequently, different sources of driving force for electroactive biomaterials and devices are explored. Finally, the biological applications of force-electric biomaterials and devices in regenerative medicine are presented, including tissue regeneration, functional modulation of organisms, and electrical stimulation therapy. The aim of this review is to emphasize the role of electrical stimulation generated by force-electric conversion biomaterials and devices on the regulation of bioactive molecules, ion channels and information transfer in living systems, and thus affects the metabolic processes of organisms. In the future, physiological modulation of electrical stimulation based on force-electric conversion is expected to bring important scientific advances in the field of regenerative medicine.

Reprogrammed glycolysis-induced augmentation of NIR-II excited photodynamic/photothermal therapy

Small molecule-based multifunctional optical diagnostic materials have garnered considerable interest due to their highly customizable structures, tunable excited-state properties, and remarkable biocompatibility. We herein report the synthesis of a multifaceted photosensitizer, PPQ-CTPA, which exhibits exceptional efficacy in generating Type I reactive oxygen species (ROS) and thermal energy under near-infrared-II (NIR-II, >1000 nm) laser excitation at 1064 nm, thereby combining photodynamic therapy (PDT) and photothermal therapy (PTT) functionalities. To enhance therapeutic efficacy, we engineered lonidamine (LND) by conjugating it with triphenylphosphonium (TPP) cations, producing LND-TPP. This compound inhibits mitochondrial glycolysis and downregulates heat shock protein 90 (HSP 90) levels in a breast cancer mouse model, potentiating both PDT and PTT. For in vivo applications, PPQ-CTPA and LND-TPP are encapsulated within the amphiphilic polymer DSPE-SS-PEG to obtain PPQ-CTPAL NPs. In breast cancer cell lines, PPQ-CTPAL NPs are decomposed by cellular GSH, simultaneously releasing the dual-functioning photosensitizer PPQ-CTPL and the mitochondria-disrupting agent LND-TPP. Upon 1064 nm laser irradiation, we found that tumor growth in breast cancer mice is effectively restrained by PPQ-CTPAL NPs. This work highlights the synergistic integration of PDT, PTT, and chemotherapy facilitated by NIR-II fluorescence, photoacoustic, and photothermal imaging under 1064 nm irradiation, underscoring the clinical potential of multifunctional phototherapeutic agents.

A two-pronged G-quadruplex construction strategy enables the development of a two-in-one aptasensor for β-lactoglobulin

Food allergies are a global concern since they threaten human health and are challenging to treat. Avoiding allergen exposure is an effective measure for vulnerable individuals, requiring reliable and simple allergen detection techniques. This can be achieved by integrating aptamer and G-quadruplex (G4) components into a sequence as a smart nucleic acid sensing nanodevice. The challenge lies in the functional structure formation of these components due to the lengthy integrated sequence and its conformational complexities. This study proposes a two-pronged strategy, encompassing both the nucleic acid sequence level and spatial structure levels, to construct a functional parallel G4 for an aptamer-loop-G4 integrated sequence, thereby enabling colorimetric detection of β-lactoglobulin (β-LG). Specifically, through comprehensive tailoring, interfering structures are excluded, and the integrated sequence is modified to adopt an appropriate G4 conformation to enhance signaling efficiency. Additionally, the topologically guided combined use of Mg2+ and K+ ions coordinates the conformational folding of the aptamer and G4 components, ensuring the recognition capacity of the aptamer. Finally, a β-LG aptasensor is established that presents advantages, such as cost-efficiency, simple operation, 35-min rapid detection, excellent specificity, and sensitivity for a linear range of nearly four orders of magnitude, meeting point-of-care testing (POCT) requirements.

Multifunctional nanozymatic biosensors: Awareness, regulation and pathogenic bacteria detection

It is estimated that approximately 700,000 fatalities occur annually due to infections attributed to various pathogens, which are capable of dissemination via multiple environmental vectors, including air, water, and soil. Consequently, there is an urgent need to enhance and refine rapid detection technologies for pathogens to prevent and control the spread of associated diseases. This review focuses on applying nanozymes in constructing biosensors, particularly their advancement in detecting pathogenic bacteria. Nanozymes, which are nanomaterials exhibiting enzyme-like activity, combine unique magnetic, optical, and electronic properties with structural diversity. This blend of characteristics makes them highly appealing for use in biocatalytic applications. Moreover, their nanoscale dimensions facilitate effective contact with pathogenic bacteria, leading to efficient detection and antibacterial effects. This article briefly summarizes the development, classification, and strategies for regulating the catalytic activity of nanozymes. It primarily focuses on recent advancements in constructing biosensors that utilize nanozymes as probes for sensitively detecting pathogenic bacteria. The discussion covers the development of various optical and electrochemical biosensors, including colorimetric, fluorescence, surface-enhanced Raman scattering (SERS), and electrochemical methods. These approaches provide a reliable solution for the sensitive detection of pathogenic bacteria. Finally, the challenges and future development directions of nanozymes in pathogen detection are discussed.

Advancements in membrane technology for efficient POME treatment: A comprehensive review and future perspectives

The treatment of POME related contamination is complicated due to its high organic contents and complex composition. Membrane technology is a prominent method for removing POME contaminants on account of its efficiency in removing suspended particles, organic substances, and contaminants from wastewater, leading to the production of high-quality treated effluent. It is crucial to achieve efficient POME treatment with minimum fouling through membrane advancement to ensure the sustainability for large-scale applications. This article comprehensively analyses the latest advancements in membrane technology for the treatment of POME. A wide range of membrane types including forward osmosis, microfiltration, ultrafiltration, nanofiltration, reverse osmosis, membrane bioreactor, photocatalytic membrane reactor, and their combinations is discussed in terms of the innovative design, treatment efficiencies and antifouling properties. The strategies for antifouling membranes such as self-healing and self-cleaning membranes are discussed. In addition to discussing the obstacles that impede the broad implementation of novel membrane technologies in POME treatment, the article concludes by delineating potential avenues for future research and policy considerations. The understanding and insights are expected to enhance the application of membrane-based methods in order to treat POME more efficiently; this will be instrumental in the reduction of environmental pollution.

Label-free turn-on electrochemiluminescence assay of β-glucuronidase at single-electrode

Electrochemiluminescence (ECL) has achieved significant commercial success over the past few decades across various fields, particularly in the healthcare industry. The measurement scheme oftentimes involves target recognition elements (e.g. catching antibodies) labeled with a suitable ECL luminophore (e.g. tris(2,2'-bipyridine)ruthenium(II))). While this approach realizes the ultrasensitive detection of various biomarkers, it is somewhat complicated strategy for certain targets such as enzymes. In this study, β-glucuronidase (B-GLU), a promising biomarker and a common water/foodstuff safety indicator, was quantified by measuring the ECL signal of fluorescent product generated from non-fluorescent substrate by the B-GLU enzyme. To this end, hot electron-induced ECL of three luminophores (fluorescein, 4-methylumbelliferyl and resorufin) that are used as building blocks to synthesize various commercially available non-fluorescent substrates was compared for the first time. To increase the appeal and practicality of this approach, the common multi-well assay format was adapted to the present type ECL by carrying out the ECL reactions at single carbon black/polystyrene electrode. In this electrochemical setup, multiple cells were fabricated on the surface of a poorly conducting substrate by attaching Teflon tape with multiple holes to the substrates surface. Sample throughput time decreases considerable as target, blank and sample signals can be simultaneously obtained from the electrochemical cells when voltage is applied across the single electrode. The detection limit for B-GLU after 2 h of incubation was 0.07 U L-1 when 4-methylumbelliferyl-β-D-glucuronide was used as the fluorogenic substrate and Br- was used as the co-reactant. B-GLU recovery rates from diluted saliva with the present ECL approach were adequate (93-103 %) and similar to those obtained with the fluorescence technique.